VolitionRX Limited
VNRX • AMEX
VolitionRX Limited is a medical - diagnostics & research company in the healthcare sector trading on AMEX, led by CEO Cameron Reynolds, with a market cap of $26.7M.
CEOCameron Reynolds
Next Earnings
Upcoming earnings announcement for VolitionRX Limited
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Revenue Estimate
$723.8K
Earnings History
Past 11 earnings reports for VolitionRX Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.05Est: -$0.05 | 0.0% | $627.3KEst: $1.6M | -61.8% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.06Est: -$0.05 | -20.0% | $406.7KEst: $357.4K | +13.8% | 10-Q/A |
| May 15, 2025 | Q1 2025 | -$0.06Est: -$0.05 | -20.0% | $246.4KEst: $1.1M | -77.2% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.06Est: -$0.05 | -20.0% | $191.7KEst: $545.3K | -64.9% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.07Est: -$0.07 | 0.0% | $474.5KEst: $652.0K | -27.2% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.08Est: -$0.09 | +11.1% | $395.8KEst: $480.0K | -17.5% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.10Est: -$0.11 | +9.1% | $171.5KEst: $390.0K | -56.0% | 10-Q |
| Mar 25, 2024 | Q4 2023 | -$0.11Est: -$0.11 | 0.0% | $244.0KEst: $450.0K | -45.8% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.11Est: -$0.13 | +15.4% | $165.2KEst: $370.0K | -55.3% | — |
| Aug 14, 2023 | Q2 2023 | -$0.14Est: -$0.15 | +6.7% | $216.3KEst: $270.0K | -19.9% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.15Est: -$0.14 | -7.1% | $149.8KEst: $420.0K | -64.3% | — |